A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies
Wen Wee, Jing Li, Nilofer S. Azad, Elaine T. Lam, Jennifer R. Diamond, Grace K. Dy, Mateusz Opyrchal, Jay Zhi, Douglas Kramer, Wing‐Kai Chan, David L. Cutler, Rudolf Kwan, Alex A. Adjei, Antonio Jimeno
Topics & Concepts
PaclitaxelMedicineOncologyInternal medicineMaximum tolerated doseChemotherapyPharmacologyCancer Treatment and PharmacologyDrug Transport and Resistance MechanismsLung Cancer Treatments and Mutations